A conversation on Psychedelic Healing with Daniel (they/he/she) @manosdelmaya on IG!\xa0 https://www.instagram.com/manosdelmaya/\xa0\nDaniel, thank you for bringing your wisdom to this conversation! You're the only human I could consider having this discussion with publicly!\xa0\nThe Context:\xa0\n\nPsychedelic Healing Converstation Preamble\xa0\n\n\n\n\n\n\nIn preparation for tomorrow's conversation, I wanted to share some of the resources I studied in 2020 + 2021 around using psychedelic healing in an effort tp manage and potentially treat my PMDD.\xa0\nTomorrow instead of providing this research live, I want to use our time to share about my experiences, and bring a true subject matter expert on the topic\xa0\U0001f33b\u2728\xa0Daniel,\xa0Mayan\xa0Mystic\xa0\U0001f6f8\xa0(he/she)I did over a year of studying on the topic, consulting with my physician and therapist in preparation for my own experiences in late 2021 and again in early 2022. \xa0I wanted to 'dump' here some of the insights that interested me in my research.\nMy biggest concern was the potential negative affect a Psychedelic would have on my ability to connect with the Spirit World, I have never wanted to risk my connection with Spirit, so I was very comforted to find the research of Psychic Medium Eileen Garret (best known for her book 'Awareness')\xa0\nSome resources:\xa0\nEileen Garrett's Work on Psychic Exploration:\n\nEileen Garrett's organization stands as a cornerstone in parapsychology and spiritual exploration, focusing on the intersection between altered states of consciousness, psychic phenomena, and the impact of substances like LSD on enhancing psychic experiences The Parapsychology Foundation: This organization preserves and shares information related to parapsychology, including Eileen Garrett's work and research.\xa0Parapsychology Foundation\n\n\nhttps://parapsychology.org/the-many-minds-of-eileen-garrett/\n\n\nhttps://psi-encyclopedia.spr.ac.uk/articles/eileen-j-garrett\xa0\n\n\nhttps://chacruna.net/eileen-garrett-and-psychedelic-experience/\xa0\n\n\nYou can use duckduckgo to find more articles, I found google to bury articles like this\n\nI discovered about Psilocybin and healing through my death doula continuing studies + research\xa0that John Hopkins University was testing high-dose Psilocybin on patients with death-anxiety in terminal illness, the results were incredible, and that really sparked my initial interest in the topic, a bit more resources and about John Hopkins Psychedelic Research:\xa0\nJohns Hopkins Research Center is a pioneering institution renowned for its groundbreaking studies exploring the therapeutic potential of psychedelics, particularly psilocybin, in treating various mental health conditions.\nhttps://hopkinspsychedelic.org/index/#research\xa0Honestly this site will keep you busy for a long time!\nJohns Hopkins University Research Data Revealed:\n\nSmoking Cessation Success Rate:\xa0One of the most notable findings is the high success rate in smoking cessation post-psilocybin therapy. Research indicated an astonishing 85% success rate in helping individuals quit smoking, far surpassing traditional methods. As someone who abused colonized tobacco for 17 years, I wish I knew this in 2002!\xa0\n\n\nReduction in Anxiety and Depression Scores:\xa0Psilocybin therapy demonstrated substantial reductions in anxiety and depression scores among participants. These improvements were observed in both immediate and long-term assessments following the therapy sessions.\n\n\nLong-Term Positive Effects:\xa0Data showcased enduring positive effects, indicating sustained improvements in emotional well-being and increased quality of life among participants even after the therapy sessions had concluded.\n\n\nEnd-of-Life Distress Alleviation:\xa0The studies revealed the profound impact of psilocybin therapy on end-of-life distress in terminally ill patients. Participants experienced a significant reduction in anxiety and increased feelings of peace and acceptance, easing their distress about death.\n\n\nSafety Profile:\xa0The data reinforced the safety profile of psilocybin th